Alliancebernstein L.P. Intra Cellular Therapies, Inc. Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,366,467 shares of ITCI stock, worth $100 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,366,467

Previous 1,580,714 13.55%

Holding current value

$100 Million

Previous $109 Million 14.44%

% of portfolio

0.03%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $13.9 Million - $17.1 Million	-214,247 Reduced 13.55%	1,366,467 $93.6 Million
Q1 2024 May 14, 2024	SELL	$64.37 - $75.65 $14.2 Million - $16.7 Million	-221,313 Reduced 12.28%	1,580,714 $109 Million
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $4.26 Million - $6.76 Million	-91,814 Reduced 4.85%	1,802,027 $129 Million
Q3 2023 Nov 14, 2023	SELL	$52.09 - $64.1 $7.66 Million - $9.42 Million	-146,961 Reduced 7.2%	1,893,841 $98.7 Million
Q2 2023 Aug 15, 2023	BUY	$54.67 - $66.44 $2.06 Million - $2.51 Million	37,752 Added 1.88%	2,040,802 $129 Million
Q1 2023 May 15, 2023	SELL	$43.8 - $56.99 $468,528 - $609,622	-10,697 Reduced 0.53%	2,003,050 $108 Million
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $8.23 Million - $10.2 Million	-186,661 Reduced 8.48%	2,013,747 $107 Million
Q3 2022 Nov 15, 2022	BUY	$42.7 - $59.99 $3.75 Million - $5.27 Million	87,821 Added 4.16%	2,200,408 $102 Million
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $86.8 Million - $132 Million	2,017,877 Added 2130.58%	2,112,587 $121 Million
Q1 2022 May 13, 2022	BUY	$38.74 - $62.09 $209,196 - $335,286	5,400 Added 6.05%	94,710 $5.8 Million
Q3 2021 Nov 10, 2021	SELL	$28.72 - $42.49 $37,336 - $55,237	-1,300 Reduced 1.43%	89,310 $3.33 Million
Q2 2021 Jul 30, 2021	SELL	$29.3 - $44.5 $152,360 - $231,400	-5,200 Reduced 5.43%	90,610 $3.7 Million
Q1 2021 May 06, 2021	BUY	$30.8 - $39.51 $36,960 - $47,412	1,200 Added 1.27%	95,810 $3.25 Million
Q3 2020 Nov 12, 2020	BUY	$17.61 - $31.86 $112,704 - $203,904	6,400 Added 7.26%	94,610 $2.43 Million
Q2 2020 Aug 13, 2020	BUY	$14.35 - $26.64 $252,560 - $468,864	17,600 Added 24.93%	88,210 $2.26 Million
Q1 2020 May 14, 2020	SELL	$12.31 - $33.12 $24,620 - $66,240	-2,000 Reduced 2.75%	70,610 $1.09 Million
Q4 2019 Feb 18, 2020	SELL	$7.26 - $38.49 $55,176 - $292,524	-7,600 Reduced 9.48%	72,610 $2.49 Million
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $76,194 - $143,106	10,200 Added 14.57%	80,210 $599,000
Q2 2019 Aug 14, 2019	SELL	$10.65 - $14.29 $37,275 - $50,015	-3,500 Reduced 4.76%	70,010 $909,000
Q2 2018 Aug 13, 2018	BUY	$17.33 - $23.4 $495,637 - $669,240	28,600 Added 63.68%	73,510 $1.3 Million
Q4 2017 Feb 13, 2018	SELL	$14.27 - $16.79 $71,350 - $83,950	-5,000 Reduced 10.02%	44,910 $650,000
Q3 2017 Nov 13, 2017	BUY	$10.77 - $22.1 $537,530 - $1.1 Million	49,910	49,910 $788,000

Others Institutions Holding ITCI

# of Institutions

400

Shares Held

87.2M

Call Options Held

309K

Put Options Held

302K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $6.92B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Intra Cellular Therapies, Inc. Transaction History